These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 15161324)
1. Evolving strategies for insulin delivery and therapy. Cefalu WT Drugs; 2004; 64(11):1149-61. PubMed ID: 15161324 [TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
4. Type II diabetes mellitus. Edelman SV Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190 [TBL] [Abstract][Full Text] [Related]
5. Unlocking the opportunity of tight glycaemic control. Far from goal. Del Prato S Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133 [TBL] [Abstract][Full Text] [Related]
6. Inhaled human insulin: new drug. No short-term advantages, too many unknowns in the long term. Prescrire Int; 2006 Dec; 15(86):203-9. PubMed ID: 17165235 [TBL] [Abstract][Full Text] [Related]
7. Advancing therapy in type 2 diabetes mellitus with early, comprehensive progression from oral agents to insulin therapy. Vinik A Clin Ther; 2007; 29 Spec No():1236-53. PubMed ID: 18046925 [TBL] [Abstract][Full Text] [Related]
8. New ways of insulin delivery. Heinemann L Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811 [TBL] [Abstract][Full Text] [Related]
10. Unlocking the opportunity of tight glycaemic control. Inhaled insulin: clinical efficacy. Scherbaum WA Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S9-13. PubMed ID: 16135137 [TBL] [Abstract][Full Text] [Related]
11. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus. Yki-Järvinen H Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990 [TBL] [Abstract][Full Text] [Related]
12. Benefits and risks of transfer from oral agents to insulin in type 2 diabetes mellitus. Evans A; Krentz AJ Drug Saf; 1999 Jul; 21(1):7-22. PubMed ID: 10433350 [TBL] [Abstract][Full Text] [Related]
13. Intradermal insulin delivery: a promising future for diabetes management. Hultström M; Roxhed N; Nordquist L J Diabetes Sci Technol; 2014 May; 8(3):453-7. PubMed ID: 24876605 [TBL] [Abstract][Full Text] [Related]
14. Novel drug delivery systems for insulin: clinical potential for use in the elderly. Belmin J; Valensi P Drugs Aging; 2003; 20(4):303-12. PubMed ID: 12641486 [TBL] [Abstract][Full Text] [Related]
15. [Biotechnological and administration innovations in insulin therapy]. Verge D Med Sci (Paris); 2004 Nov; 20(11):986-98. PubMed ID: 15525494 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological management of type 2 diabetes mellitus: rationale for rational use of insulin. Chan JL; Abrahamson MJ Mayo Clin Proc; 2003 Apr; 78(4):459-67. PubMed ID: 12683698 [TBL] [Abstract][Full Text] [Related]
18. Treatment of diabetes mellitus using an external insulin pump in clinical practice. Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117 [TBL] [Abstract][Full Text] [Related]
19. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery. Klonoff DC Pediatr Endocrinol Rev; 2003 Dec; 1(2):94-100. PubMed ID: 16437014 [TBL] [Abstract][Full Text] [Related]
20. Feasibility and outcomes of insulin therapy in elderly patients with diabetes mellitus. Saudek CD; Hill Golden S Drugs Aging; 1999 May; 14(5):375-85. PubMed ID: 10408737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]